Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine – a Phase I trial

MICRO-ABSTRACT: In a Phase I dose-finding study of metronomic daily oral vinorelbine in advanced non-small-cell lung cancer, a recommended dose was established for this therapeutic approach. In addition, this trial revealed promising efficacy data and an acceptable tolerability profile. The observed...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Onco Targets Ther
Egile Nagusiak: Guetz, Sylvia, Tufman, Amanda, von Pawel, Joachim, Rittmeyer, Achim, Borgmeier, Astrid, Ferré, Pierre, Edlich, Birgit, Huber, Rudolf Maria
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2017
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5328303/
https://ncbi.nlm.nih.gov/pubmed/28260922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S122106
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak